Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. (Q40231478)
Jump to navigation
Jump to search
scientific article published on 14 October 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. |
scientific article published on 14 October 2013 |
Statements
Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial (English)
Hong-Hu Zhu
De-Pei Wu
Jie Jin
Jian-Yong Li
Jun Ma
Jian-Xiang Wang
Hao Jiang
Sai-Juan Chen
14 October 2013